Background and Purpose-Vasomotor reactivity (VMR) testing can identify patients with hemodynamically critical cerebrovascular disease. The use of VMR has been limited by the invasiveness of most of the available methods and of acetazolamide as VMR stimulus. In the present study, we evaluated a completely noninvasive VMR approach by combining quantitative phase-contrast magnetic resonance imaging (MRI) with a breath-hold challenge. Methods-Volume flow rates in the right and left internal carotid artery (ICA), basilar artery (BA), superior sagittal sinus, and sinus rectus were measured on 2-dimensional phase-contrast MR angiograms (MRAs) with a temporal resolution of 4.3 seconds. In 20 healthy control subjects, the VMR was assessed during 2 consecutive 30-second periods of breath-holding. Results-A flow increase on breath-holding of 66% was found for the left ICA (240Ϯ54 mL/min to 398Ϯ120 mL/min; PϽ0.01), 59% for the right ICA (253Ϯ98 mL/min to 402Ϯ159 mL/min; PϽ0.01), 71% for the BA (107Ϯ48 mL/min to 184Ϯ79 mL/min; PϽ0.01), 62% for the superior sagittal sinus (232Ϯ75 mL/min to 375Ϯ130 mL/min; PϽ0.01), and 65% for the sinus rectus (77Ϯ30 mL/min to 127Ϯ38 mL/min; PϽ0.01). The coefficient of variation for the total volume flow increase in the brain feeding arteries (ICAs and BA) between the first and the second breath-holds was 18%. 
V asomotor reactivity (VMR), ie, vasodilatory response of the cerebral resistance vessels, has been demonstrated to be of prognostic importance in cerebrovascular disease. 1, 2 Thus far, the use of VMR has been limited by the invasiveness of most of the available methods and of acetazolamide as VMR stimulus. Firstly, the methods to monitor cerebral hemodynamics, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), use (ionizing) radiation or administration of intravenous agents. 3, 4 Secondly, the most frequently used VMR stimuli require the intravenous administration of acetazolamide or a carbon dioxide (CO 2 ) challenge with a CO 2 mask. [5] [6] [7] However, simple breath-holding has also been proposed as a noninvasive alternative. 8, 9 Currently, noninvasive methods to monitor cerebral hemodynamics are transcranial doppler (TCD) sonography and phase-contrast magnetic resonance imaging (MRI).
With phase-contrast MRI, absolute volume flow and changes in volume flow can be obtained. Resting phasecontrast volume flow measurements have been used to evaluate cerebral hemodynamic impairment in patients with obstructive disease of the internal carotid artery (ICA) or posterior circulation, 10 -12 arteriovenous malformations, 13, 14 and the evaluation of vascular interventions, such as bypass surgery, 15, 16 or carotid endarterectomy. 17 Recently, in vivo studies have demonstrated the reproducibility of phasecontrast volume flow measurements in rest and volume flow increase on an acetazolamide challenge. 18, 19 Thus far, no studies evaluated the amount and reproducibility of the volume flow increase in the arteries in the neck on a breath-hold challenge. Current abdominal and cardiac MRI scan protocols frequently use breath-holding periods of 15 to 30 seconds to decrease respiratory motion artifacts. Therefore, breath-holding combined with MRI volume flow measurements may be added to existing scan protocols to measure VMR noninvasively.
In the present study, we evaluated with quantitative phasecontrast MRI the volume flow increase on a 30-second breath-hold challenge. The relative and absolute change in volume flow and reproducibility were assessed for the left and right ICAs, the basilar artery (BA), and dural venous sinus flow (sinus rectus, superior sagittal sinus).
Materials and Methods

MRI
MRI was performed on a 1.5-T whole-body system (Gyroscan ACS-NT; Philips Medical Systems). On the basis of a localizer MR angiography (MRA) slab in the sagittal plane, a 2-dimensional phase-contrast slice was positioned at the level of the skull base to measure the volume flow in the ICAs, the BA, the sinus rectus, and the superior sagittal sinus (Figure 1 ). The MRA volume flow measurements in the present study are derived from a previously developed and optimized protocol (nontriggered; repetition time [TR], 16 ms; echo time [TE], 9 ms; flip angle, 7.5°; slice thickness, 5 mm; field of view, 250ϫ250 mm; matrix size, 256ϫ256; 8 averages; velocity sensitivity, 150 cm/s). 20, 21 A series of 80 dynamics was acquired with a 4.3-second temporal resolution per dynamic leading to a scan time of 5 minutes 44 seconds. Two periods of breath-holding, each with a 30-second duration (7 dynamics), were performed during the series of dynamics. The interval between the 2 breath-holding periods was 1 minute long. Breath-holding was started after a normal inspiration to avoid artificially lowering of the cerebral perfusion after a deep inspiration (Valsalva effect). 22 Adequate breath-holding during the 30-second period was monitored by a pressure sensor under a respiratory band located at the abdomen. To restrain bulk motion, subjects were stabilized using foam pads and a head strap.
Subjects and Data Analyses
Twenty healthy young volunteers (age range 22 to 32 years; 10 females, 10 males) were imaged using this protocol. Subjects gave informed written consent before participating. The study protocol was approved by the institutional review board.
On an independent workstation, quantitative flow values and maximum flow velocities were calculated in the ICAs, BA, sinus rectus, and superior sagittal sinus by integrating across manually drawn regions of interest that enclosed the vessel lumen closely ( Figure 1 ). Resting volume flow and maximum flow velocity values were obtained by averaging over 5 dynamics before the first breath-holding period and 5 dynamics between the 2 breath-holding periods. Volume flow and maximum flow velocity during the first and second breath-holding periods were obtained by averaging the flow values of 2 dynamics obtained 25.8 to 34.4 seconds after the beginning of the breath-hold challenges. To determine the average percent increase in flow volume and velocity, the response of the first and the second breath-holding period was averaged before calculating a group response. The breath-holding index (BHI), 8 quotient of percentage volume flow or flow velocity increase and time of breath holding, was calculated based on the mean time from the start of breath-holding (30.1 seconds) for these 2 dynamics.
Statistical Analysis
Quantitative volume flow and flow velocity was expressed as meanϮSD. Differences in volume flow between the rest and the breath-holding period and differences in volume flow and reactivity between the first and the second breath-holds were analyzed with the Student t test for 2 related samples. In all tests, PϽ0.05 was considered statistically significant.
Reproducibility of the increase in volume flow on a breath-hold challenge was analyzed according to the method of Bland and Altman. 23 With the difference between the volume flow increase for the first and the second breath-holding period, the standard deviation of the difference (SDD) was calculated. The SDD is a measure of the repeatability of the method. The 95% limits of agreement were calculated (ie, the mean differenceϮ1.96 ϫ SDD). The coefficient of variation was calculated (ie, the SDD given as a percentage of the mean cerebral blood flow). Figure 2 shows the arterial and venous volume flow in rest and during 2 30-second breath-holding periods for an average subject. For the right and left ICAs, BA, sinus rectus, and superior sagittal sinus, an increase in volume flow was found during breath-holding, which returned to baseline flow values soon after the breath-holding period.
Results
In Figure 3a , the average (nϭ20 subjects) baseline volume flow and volume flow during breath-holding are shown in mL/min (mean, SD) for the right ICA, left ICA, BA, sinus rectus, and superior sagittal sinus. The flow increase on breath-holding was 59% for the right ICA (253Ϯ98 mL/min to 402Ϯ159 mL/min; PϽ0.01), 66% for the left ICA (240Ϯ54 mL/min to 398Ϯ120 mL/min; PϽ0.01), 71% for the BA (107Ϯ48 mL/min to 184Ϯ79 mL/min; PϽ0.01), 65% for the sinus rectus (77Ϯ30 mL/min to 127Ϯ38 mL/min; PϽ0.01), and 62% for the superior sagittal sinus (232Ϯ75 mL/min to 375Ϯ130 mL/min; PϽ0.01). The BHI for the volume flow increase was 1.96 for the right ICA, 2.19 for the left ICA, 2.35 for the right BA, 2.16 for the sinus rectus, and 2.06 for the superior sagittal sinus.
In Figure 3b , the maximum flow velocity and maximum flow velocity during breath-holding are shown in centimeters per second (mean, SD) for the right and left ICAs, BA, sinus rectus, and superior sagittal sinus. The flow velocity increase on breath-holding was 48% for the right ICA (28Ϯ10 cm/sec to 42Ϯ14 cm/sec; PϽ0.001), 53% for the left ICA (28Ϯ11 cm/sec to 43Ϯ21 cm/sec; PϽ0.01), 47% for the BA (24Ϯ13 cm/sec to 35Ϯ20 cm/sec; PϽ0.01), 41% for the sinus rectus (19Ϯ7 cm/sec to 26Ϯ9 cm/sec; PϽ0.01), and 75% (19Ϯ9 cm/sec to 33Ϯ15 cm/sec; PϽ0.01) for the superior sagittal sinus. The BHI for the flow velocity increase was 1.59 for the right ICA, 1.76 for the left ICA, 1.56 for the BA, 1.36 for the sinus rectus, and 2.49 for the superior sagittal sinus.
No significant difference in baseline volume flow between the first and the second breath-hold was found for the right ICA (248 mL/min versus 231 mL/min), the left ICA (254 mL/min versus 252 mL/min), the BA (109 mL/min versus 105 mL/min), the sinus rectus (73 mL/min versus 80 mL/ min), and the superior sagittal sinus (234 mL/min versus 229 mL/min). Furthermore, no significant difference in volume flow increase between the first and the second breath-holding period was found. The coefficient of variation of the volume flow increase between the first and the second breath-hold was 33% for the right ICA, 30% for the left ICA, 25% for the BA, 34% for the sinus rectus, and 30% for the superior sagittal sinus. The coefficient of variation for the total volume flow increase in the brain feeding arteries (ICAs and BA) was 18%.
Discussion
In the present study, we show the absolute volume flow increase, relative volume flow increase, and reproducibility of noninvasive VMR measurements with phase-contrast MRI in combination with a breath-hold challenge. Optimal angulation of the 2-dimensional phase-contrast MRI scan allowed simultaneous assessment of the change in volume flow of the right and left ICAs, BA, sinus rectus, and superior sagittal sinus.
A 384 mL/min (64%) increase in total volume flow was found of the brain feeding arteries on breath-holding. In previous phase-contrast MRA studies, an acetazolamide challenge resulted in 278 mL/min (46%) and 300 mL/min increase in total volume flow. 18, 24 Furthermore, in a color Doppler study, a volume flow increase of 215 mL/min (50%) was found for an acetazolamide challenge and 163 mL/min (47%) for a CO 2 challenge. 25 We found a significant volume flow increase for the sinus rectus and the superior sagittal sinus. These findings are in agreement with the tight coupling between arterial and venous flow to prevent elevation of intracranial pressure. 26 The increase in ICA flow velocity of 50% is in agreement with the 40% to 45% increase in arterial flow velocity found with breath-holding techniques 8, 22 and the 50% to 60% increase in flow velocity found with TCD and CO 2 challenges. 27 ,28 A 47% flow velocity increase was found in the BA in our study compared with a 54% increase previously found for a 30-second breath-hold challenge and 78% for a CO 2 challenge. 29, 30 With a CO 2 stimulus, a VMR of 91% was previously reported for the sphenoparietal sinus 28 compared with a VMR of 75% of the superior sagittal sinus and 41% for the sinus rectus in our study. Furthermore, the absolute flow velocities of the superior sagittal sinus in rest and during activation were in agreement with literature values. 28 The coefficient of variation for the volume flow increase in the brain feeding arteries between the first and the second breath-hold was 18% compared with a coefficient of variation of 28% found in a previous phase-contrast study with an intravenous acetazolamide injection. 18 The average time between the first and the second measurement was 15 days in the study of Spilt et al compared with a 1-minute interval in our study. Therefore, the minimal effect of physiological flow variations may have caused the higher reproducibility of our VMR study. Furthermore, the reactivity after acetazolamide was assessed with a single phase-contrast MRA scan of 36 seconds, 18 instead of continuous monitoring of the volume flow. Although previous TCD studies reported a better reproducibility compared with MRI-based methods, the presented method has several potential advantages for clinical studies. Firstly, phase-contrast flow measurements combined with a breath-hold challenge can be added to existing MRI protocols. Secondly, in addition to reactivity measurements absolute values of the total volume flow (mL/min) are obtained. Total volume flow may be useful as a general measure of cerebral hemodynamic status in patients with generalized cerebrovascular diseases 31 or potentially in patients with (vascular) dementia.
Our results show a higher increase in flow velocity in the superior sagittal sinus (75%) compared with the flow velocity increase of the ICAs (50%) and BA (47%). This finding is in agreement with a previous study, in which a higher increase in velocity of the sphenoparietal sinus was found compared with the velocity increase in the middle cerebral artery. 28 In the present study, no significant difference was found in volume flow increase in the superior sagittal sinus compared with the ICAs and BA. This difference in response between the flow velocity and volume flow of the arteries and veins can be explained by a diameter increase of the major brain feeding arteries and a not extensible venous caliber of the superior sagittal sinus. 25, 28 An arterial vasodilatation results in relatively lower increase in flow velocity. The advantage of MRA phase-contrast volume flow (mL/min) measurements above flow velocity-based (cm/sec) techniques is the integration of flow velocity over the cross-sectional vessel area, which will reflect more closely the change in cerebral blood flow at the tissue level. 24 The difference in total volume flow between the arteries and veins in the present study can be explained by the veins in which no flow measurements were performed, such as the veins draining directly in the left and right transverse sinuses.
In the present study, the phase-contrast MRI and breathholding protocol were evaluated in healthy control subjects. Several TCD studies used the same 30-second duration of breath-holding in stroke patients. 2, 32 Furthermore, cardiac MRI studies in acutely ill patients, with expiratory breathholding for artifact reduction, indicate that breath-holding can be performed in clinical settings. 33 In stroke patients, the breath-holding index can be used instead of the percentage flow/velocity increase to account for a submaximal challenge. 8 In the present study, in control subjects, the short (1 minute) time interval between breath-holding periods did not result in VMR differences between the first and the second breath-hold. Because such effects may occur in stroke patients, longer intervals between breath-holding periods (ie, 2 to 3 minutes) should be used in clinical settings.
In conclusion, MRA phase-contrast volume flow measurements with a breath-hold challenge allow for complete noninvasive and reproducible assessment of cerebrovascular reactivity. The breath-hold challenge is already used for other purposes (artifact reduction) in daily MRI scan protocols. Furthermore, volume flow phase-contrast MRA scans reflect the change in cerebral blood flow independent of arterial vasodilatation. When added to existing MRI scan protocols, phase-contrast MRI may increase the availability of the valuable prognostic information provided by VMR in patients with hemodynamically critical cerebrovascular disease. 
